Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Reverse transcriptase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Trypanosoma congolense | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Trypanosoma brucei | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Plasmodium yoelii | integrase-related | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Schistosoma mansoni | hypothetical protein | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | regulator of G protein signaling | 0.026 | 0.0711 | 0.0711 |
Schistosoma mansoni | regulator of G protein signaling | 0.026 | 0.0711 | 0.0711 |
Echinococcus granulosus | G protein coupled receptor kinase 1 | 0.1215 | 0.8015 | 0.7863 |
Trichomonas vaginalis | conserved hypothetical protein | 0.026 | 0.0711 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.026 | 0.0711 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.026 | 0.0711 | 0.5 |
Loa Loa (eye worm) | G protein-coupled receptor kinase 1 | 0.1085 | 0.7016 | 0.6787 |
Schistosoma mansoni | regulator of G protein signaling | 0.026 | 0.0711 | 0.0711 |
Schistosoma mansoni | regulator of G protein signaling 17 19 20 (rgs17 19 20) | 0.026 | 0.0711 | 0.0711 |
Trichomonas vaginalis | conserved hypothetical protein | 0.026 | 0.0711 | 0.5 |
Echinococcus multilocularis | G protein coupled receptor kinase 1 | 0.1215 | 0.8015 | 0.7863 |
Trichomonas vaginalis | regulator of G protein signaling 5, rgs5, putative | 0.026 | 0.0711 | 0.5 |
Schistosoma mansoni | regulator of G protein signaling | 0.026 | 0.0711 | 0.0711 |
Schistosoma mansoni | z-protein (S1r protein) | 0.026 | 0.0711 | 0.0711 |
Echinococcus multilocularis | beta adrenergic receptor kinase | 0.1475 | 1 | 1 |
Schistosoma mansoni | regulator of G protein signaling | 0.026 | 0.0711 | 0.0711 |
Entamoeba histolytica | hypothetical protein | 0.026 | 0.0711 | 0.5 |
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.1085 | 0.7016 | 0.6787 |
Echinococcus granulosus | [G-protein-coupledreceptor] kinase | 0.1085 | 0.7016 | 0.6787 |
Trichomonas vaginalis | conserved hypothetical protein | 0.026 | 0.0711 | 0.5 |
Loa Loa (eye worm) | AGC/GRK/BARK protein kinase | 0.1475 | 1 | 1 |
Brugia malayi | Probable G protein-coupled receptor kinase F19C6.1, putative | 0.1344 | 0.9001 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.026 | 0.0711 | 0.5 |
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.1344 | 0.9001 | 0.8924 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1475 | 1 | 1 |
Schistosoma mansoni | regulator of G protein signaling 3 rgs3 | 0.026 | 0.0711 | 0.0711 |
Entamoeba histolytica | hypothetical protein | 0.026 | 0.0711 | 0.5 |
Trypanosoma brucei | RNA helicase, putative | 0.0167 | 0 | 0.5 |
Schistosoma mansoni | axis inhibition protein axin | 0.026 | 0.0711 | 0.0711 |
Schistosoma mansoni | regulator of G protein signaling 17 19 20 (rgs17 19 20) | 0.026 | 0.0711 | 0.0711 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1344 | 0.9001 | 0.9001 |
Brugia malayi | Probable G protein-coupled receptor kinase F19C6.1, putative | 0.1085 | 0.7016 | 0.7605 |
Echinococcus multilocularis | G protein coupled receptor kinase 6 | 0.1085 | 0.7016 | 0.6787 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1475 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.026 | 0.0711 | 0.5 |
Schistosoma mansoni | axis inhibition protein axin | 0.026 | 0.0711 | 0.0711 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 6.1 nM | Inhibition of HIV1 reverse transcriptase using poly(rA)/oligo(dT)15 as substrate after 60 mins by fluorescence assay | ChEMBL. | 23673016 |
permeability (ADMET) | = 29 ucm/s | Permeability from basolateral to apical side of human Caco2 cells at 10 uM after 30 to 90 mins by LC-MS/MS analysis | ChEMBL. | 23673016 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.